The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Follow-On Investment into Existing Royalty Partner

25 Feb 2022 07:00

RNS Number : 7867C
Duke Royalty Limited
25 February 2022
 

25 February 2022

 Duke Royalty Limited

 

("Duke Royalty", "Duke" or the "Company")

 

Follow-On Investment into Existing Royalty Partner

 

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to announce a follow-on investment of £1.5 million into its existing royalty partner Lynx Equity (UK) Ltd. ("Lynx UK").

 

Highlights:

 

· Lynx UK will use this contribution from Duke to acquire Danish equipment manufacturer, Obel-P Automation A/S ("Obel-P"), which was agreed earlier this month

· This is Lynx UK's eighth acquisition completed within the UK and Europe and Duke's follow-on investment further diversifies both Duke's portfolio and Lynx UK's revenue and EBITDA base

· The financing increases Duke's total investment into Lynx UK to £15.0 million and marks the realisation of the initial financing commitment as its preferred European capital partner as announced in October 2017

· All other terms of the £1.5 million contribution are the same as Duke's previous investment made into Lynx UK

 

Neil Johnson, CEO of Duke Royalty, said:

 

"Since 2017, Lynx UK has continued to find long-standing, profitable private businesses that meet our shared criteria for investment. Our near five-year partnership for expanding into Europe has been a collective success for Lynx UK, the businesses owners they acquire, Duke and our shareholders.

 

"Lynx Equity Limited, based in Canada, has acquired over 50 companies in the last 15 years and has revenues of over C$500 million (£300m), which speaks to their success and the scale of the opportunity. Brad and his team were our first royalty partner deploying a buy-and-build strategy. Their strong financial track record is due to a keen focus on acquiring profitable 'old world' companies at a reasonable multiple, which aligns with Duke Royalty's royalty criteria."

 

Brad Nathan, President of Lynx Equity Limited, said:

 

"We looked at various funding sources when we set up our European operation and felt that Duke's long dated capital perfectly suited our expansion plans in this new geography. Since then, the partnership has worked very well and I am delighted that we have now completed our eighth acquisition using Duke's capital. We look forward to maintaining and expanding the close relationship that we have built with Duke over the last four years."

 

About Obel-P

 

Founded in 1954, Obel-P's is an equipment manufacturing business located in Herning, Denmark. The Company's equipment is purchased by wood product manufacturers seeking to optimize their assembly processes and reduce overall production costs. Obel-P's product lines include mounting machinery designed to move wooden components along the assembly line as well as high frequency presses and generators used to combine individual components at the end of the production process.

 

About Lynx UK

 

Duke entered into a royalty agreement with Lynx UK, a wholly-owned subsidiary of Lynx Equity Limited, on 5 October 2017 to finance Lynx UK's acquisition strategy. The total financing commitment was £15.0 million, to be drawn in tranches, with proceeds being used to acquire target companies in Europe.

 

Lynx UK's European portfolio currently includes UK's Signalhome, Label Express and Day 2 Interiors, and Denmark's PartnerService, Sundby Trapper, Arkas, Yding Gruppen and Obel-P Automation.

 

With sales in excess of C$500 million, Lynx Equity Limited is a diversified private equity firm focused on acquiring small and medium-sized businesses from owners looking to retire or seeking strategic opportunities. Lynx targets acquisitions of companies with EBITDA between US$750,000 to US$3 million and utilises a buy and hold strategy.

 

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

Canaccord Genuity

(Joint Broker)

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/ Richard Bicknell/ Max Richardson

+44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTTIMBTMTTTTRT
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.